Urgent Unmet Need for Early Detection 

Transcript:

There is an urgent unmet need for early detection in lung cancer.  Right now in the United States, 350 people die every single day from lung cancer and the reason is because most of the time it's detected too late. 

Currently only around 20% of lung cancers are caught early and are often caught by chance, when the patient happens to get a CT Scan and they find an abnormal growth. These are called indeterminate lung nodules, and it's these nodules that can be very challenging for the doctors to evaluate, particularly if small.  

Right now, there's two pathways clinicians can follow. There's the wait and see pathway and biopsy.  Neither is optimal for the patient, particularly as one in five biopsies results in an adverse event and 40% return as not having lung cancer. 

Clinicians are looking for something to help with that evaluation process. And that's why we developed the LungLB test. It starts off with a simple blood draw, and is simply sent to us in a pre-paid mailer; no ice required! 

We then process it in our CLIA and CAP certified lab in California, where we perform the LungLB test and deliver a result back to the clinician within a week.  

We recently concluded our clinical validation study showing a 80% positive predictive value in cases of indeterminate nodules less than 15 mm in diameter found by CT scan.   

As a precursor to our full commercial launch later this year, we have launched our Early Access Program. If you would like to participate, please click the Order LungLB Test button below.